Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
CA 2407292 A1 · Owner: Virion Systems, Inc. · Inventors: Johnson, Leslie S.; Prince, Gregory
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Therapeutically effective anti-viral compositions useful especially against , respiratory diseases caused or mediated by respiratory syncytial virus (RSV) are disclosed, wherein said compositions comprise at least one anti-RSV antibody, including high affinity antibodies and an additional anti-, inflammatory agent especially corticosteroids, as well as anti-inflammatory antibodies, especially anti-interleukin-6. Also disclosed are methods of using such compositions to treat and/or prevent respiratory diseases. Such compositions may optionally contain other non-antibody anti-viral agents.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 3, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 3, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 3, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.